Daniel Lagasse
FDA Investigator
- Daniel Lagasse first started conducting FDA inspections in 2019, with the last inspection in 2022. Over that time, Daniel Lagasse has conducted 2 inspections at 2 companies across 2 sites.
Get Daniel Lagasse's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out of stock
FDA 483 Bayer Healthcare, LLC, Berkeley | 2019
Out of stock